Cardiac Catheters And Guidewires Market (2026 - 2033)

Cardiac Catheters And Guidewires Market Summary

The global cardiac catheters and guidewires market size was valued at USD 17.3 billion in 2025 and is projected to grow from USD 18.6 billion in 2026 to USD 29.6 billion by 2033, at a CAGR of 6.8% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 44.0% in 2025. The industry growth is attributed to technological advancements, initiatives by various governments & organizations, and the rising incidence of chronic diseases.

Increasing cases of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and stroke, are also leading to a surge in the consumption of diagnostic and interventional cardiac procedures using catheters and guidewires. The growing adoption of minimally invasive surgical procedures for faster patient recuperation, shorter hospital stays, and lower complications is expected to propel market growth.

The increasing prevalence of cardiovascular diseases and other chronic conditions globally is expected to drive the demand for cardiac catheters and guidewires during the forecast period. The increasing elderly population, high prevalence of coronary artery diseases, adoption of minimally invasive cardiovascular treatments, and expanding healthcare expenditures in regions such as North America, Europe, and Asia are contributing to market growth.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Increasing incidence of cardiovascular diseases, technology advancements in interventional cardiology, and increased investment in healthcare infrastructure are also contributing to the market expansion during the forecast period. According to the Centers for Disease Control and Prevention (CDC), heart disease remained the leading cause of death in the U.S., accounting for 919,032 deaths in 2023, equivalent to approximately 1 in every 3 deaths.

In addition, a heart attack occurs approximately every 34 seconds in the U.S. In addition, a heart attack occurs approximately every 40 seconds in the U.S. Furthermore, according to the World Health Organization (WHO), cardiovascular diseases (CVDs) remain the leading cause of death globally, accounting for an estimated 19.8 million deaths in 2022, representing approximately 32% of all global deaths. The rise in the number of cardiovascular diseases, along with the development of interventional cardiology devices and the increasing expenditure on healthcare infrastructure, is anticipated to drive market growth during the forecast period.

Market Dynamics

Analyst’s Perspective

The cardiac catheters and guidewires market is witnessing steady growth, driven by the rising prevalence of cardiovascular diseases and increasing adoption of minimally invasive procedures. Expanding healthcare infrastructure and improved access to cardiac care in developing regions are further supporting market growth. Innovations such as steerable guidewires, drug-coated catheters, and AI-enabled imaging are improving procedural accuracy and patient outcomes. Companies focusing on product innovation, regulatory approvals, physician training, and strong distribution networks are expected to gain a competitive advantage.

Product Insights

The cardiac catheters segment led the market with the largest revenue share of around 84.0% in 2025. Cardiac catheters are generally used to open blocked blood vessels, allowing enhanced blood flow. It gets inflated when inserted inside the blood vessels and thereby increases the blood flow. Cardiac catheters are mainly used in cardiac catheterization, angioplasty, PCI, and other interventional procedures. Similarly, in the case of angioplasty and other interventional procedures, the insertion of a catheter is the initial step in these procedures. The increasing cases of cardiovascular diseases globally are one of the major factors contributing to the segment's growth.

The cardiac guidewires segment is expected to grow at a notable CAGR over the forecast period. The increasing prevalence of cardiovascular diseases is significantly driving demand for advanced interventional devices. This segment is expected to experience consistent growth throughout the forecast period, owing to a growing volume of minimally invasive cardiovascular procedures worldwide. Cardiac guidewires are an essential component of interventional cardiology procedures, as they provide access, navigation through intricate vascular anatomy, and secure placement of balloons, stents, catheters, and other interventional devices. Furthermore, the increased geriatric population and heart-related disorders are projected to support the market growth over the forecast period.

End-use Insights

The hospitals segment led the market with the largest revenue share of around 41.0% in 2025, due to the high incidence of cardiovascular diseases globally. The rising number of hospitals globally is also anticipated to support the segment growth over the forecast period. Increased healthcare spending, the growing number of hospitals, particularly in developing countries, and increasing investment in catheterization labs will also continue to drive demand. Besides, the increasing number of minimally invasive cardiovascular surgeries in hospital settings is anticipated to sustain the segment growth over the forecast period.

The ambulatory surgical centers (ASCs) segment is estimated to register at the fastest CAGR over the forecast period. Ambulatory surgery facilities, sometimes referred to as outpatient surgery centers, are frequently chosen by patients having less involved surgeries that require only a brief hospital stay. Rapid healing is possible with minimally invasive interventional techniques, which also have a short hospital stay. Thus, patients opting for such procedures prefer to choose ASCs. For instance, percutaneous transluminal coronary angioplasty (PTCA) and percutaneous transluminal angioplasty (PTA) are minimally invasive interventional procedures that enable rapid healing, allowing patients to return to their normal lives within a short period. Currently, the demand for minimally invasive procedures is increasing globally owing to their several advantages, which, in turn, is expected to boost the demand for ASCs.

Regional Insights

North America dominated the global cardiac catheters and guidewire market with the largest revenue share of approximately 44.0% in 2025. This can be attributed to several factors, such as increased adoption of cardiac catheters and guidewire technology in primary care settings, improved accessibility, and high healthcare spending in countries with efficient reimbursement policies. Technological innovations and the growing incidence of chronic conditions are anticipated to further propel the region’s growth. The increasing incidence of chronic diseases in this region, such as cardiovascular disorders, has created a high demand for imaging analysis. 

To learn more about this report, Download Free Sample Report

Asia Pacific Cardiac Catheters and Guidewires Market Trends

The cardiac catheters and guidewire market in the Asia Pacific is expected to grow at the fastest CAGR over the forecast period. The rising prevalence of cardiac diseases has created a demand for cardiac catheters & guidewires equipment in APAC countries. Furthermore, with some of the highest diabetes rates in the world, India and China have been the most affected countries. Diabetes claims the lives of about 1.5 million people every year, according to WHO estimates. The population of ASEAN countries is expected to reach 705 million by 2028.

Key Cardiac Catheters and Guidewires Company Insights

The cardiac catheters and guidewire market is highly fragmented, with a majority of the market share held by many small companies. The companies are focusing on adopting several strategies, including product launches, strategic collaborations, and acquisitions, to strengthen their market presence and further contribute to market growth. Furthermore, companies are increasingly expanding manufacturing facilities and distribution channels due to the global increase in demand for cardiovascular devices.

Key Cardiac Catheters and Guidewires Companies:

The following key companies have been profiled for this study on the global cardiac catheters and guidewire market.

• Abbott

• Boston Scientific Corp.

• Getinge AB

• Biosense Webster, Inc. (Part of Johnson & Johnson)

• Terumo Medical Corp.

• BIOTRONIK SE & Co. KG

• Medtronic

• CORDIS (A, Cardinal Health Company)

• QXMédical

• Teleflex Inc.

• B. Braun

• C. R., Bard, Inc. (has joined BD)

• Cardinal Health

• Merit Medical Systems

• NIPRO

• BrosMed Medical Co., Ltd.

Recent Developments:

• In July 2025, Teleflex completed the acquisition the vascular intervention business of BIOTRONIK SE & Co. KG for approximately USD 796.3 million. The acquired business has expanded the portfolio of coronary and peripheral intervention products and devices, including balloon catheters and stents.

• In May 2025, Abbott introduced the TactiFlex Sensor-Enabled Ablation Catheter in India, offering flexible-tip and contact-force sensing technology, aiming to enhance the accuracy of AF procedures.

Global Cardiac Catheters And Guidewires Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cardiac catheters and guidewires market report based on product, end-use, and region:

To learn more about this report, Download Free Sample Report

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Cardiac Catheters

    • Electrophysiology catheters

    • PTCA balloon catheters

    • IVUS catheters

    • PTA balloon catheters

    • Guide extension catheter

    • Others

  • Cardiac Guidewires

• End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

  • Clinics

  • Ambulatory Surgical Centers

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • Saudi Arabia

    • South Africa

    • UAE

    • Kuwait